VisualSonics is the world's leading developer of high-resolution,
ultrasound-based, in vivo micro-imaging systems designed specifically for
non-invasive preclinical research. The company's enabling micro-ultrasound
technology, the Vevo 770, allows researchers at the world's most prestigious
pharmaceutical and biotechnology companies, hospitals and research centers
to conduct genetic research, phenotypic study and drug development.
Micro-ultrasound is the fastest growing preclinical imaging modality.
This enabling technology is facilitating research in cardiac and vascular
disease, cancer, stem cell research and developmental biology. When compared
to other imaging options, only micro-ultrasound has the combination of
high-resolution, real-time imaging, in vivo detection and analysis,
reasonable cost, ease-of-use, portability and no negative biological
More information on VisualSonics and micro-ultrasound can be found at